MYHEALTHSENTRY Trademark

Trademark Overview


On Monday, July 23, 2012, a trademark application was filed for MYHEALTHSENTRY with the United States Patent and Trademark Office. The USPTO has given the MYHEALTHSENTRY trademark a serial number of 85684506. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 23, 2017. This trademark is owned by GeneNews Limited. The MYHEALTHSENTRY trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

blood drawing apparatus; diagnostic kits; diagnostic kits comprising molecular biological reagents useful for detecting gene expression products, including ribonucleic acid (RNA) or proteins, as an indication of body state, including body health, condition, disease, response to external stimuli, or response to therapeutic treatment; laboratory testing services; patient triage or risk stratification services, including determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients; diagnostic services, including diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical and diagnostic services, including diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying p...
myhealthsentry

General Information


Serial Number85684506
Word MarkMYHEALTHSENTRY
Filing DateMonday, July 23, 2012
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 23, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesblood drawing apparatus; diagnostic kits; diagnostic kits comprising molecular biological reagents useful for detecting gene expression products, including ribonucleic acid (RNA) or proteins, as an indication of body state, including body health, condition, disease, response to external stimuli, or response to therapeutic treatment; laboratory testing services; patient triage or risk stratification services, including determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients; diagnostic services, including diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical and diagnostic services, including diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, and monitoring of patient health progression; medical and diagnostic services, namely, evaluating clinical trial progress, and drug monitoring; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating treatment progression, and prognosing disease or disease progression; providing genomic, proteomic and gene expression profiles useful in evaluating the efficacy and toxicity of treatments, and identifying disease heredity risk factors; research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; computer services, including providing a website for patients and medical professionals featuring educational information about personalized health management, disease, and disease risk assessment services and screening products; computer services, including computer tracking of and providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics; computer services, including maintaining and providing access to a patient registry containing personalized health management information accessible via global, national and local computer network
Pseudo MarkMY HEALTH SENTRY

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 30, 2012
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGeneNews Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRichmond Hill, Ontario L4B2N3
CA

Trademark Events


Event DateEvent Description
Monday, January 23, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 23, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 23, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 2, 2016INQUIRY AS TO SUSPENSION MAILED
Monday, May 2, 2016SUSPENSION INQUIRY WRITTEN
Tuesday, April 5, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, September 30, 2015LETTER OF SUSPENSION MAILED
Tuesday, September 29, 2015SUSPENSION LETTER WRITTEN
Monday, September 21, 2015LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, September 14, 2015ASSIGNED TO LIE
Monday, March 9, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, September 9, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 11, 2014ASSIGNED TO EXAMINER
Tuesday, March 4, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, September 3, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 25, 2013LETTER OF SUSPENSION MAILED
Monday, February 25, 2013SUSPENSION LETTER WRITTEN
Friday, February 15, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 15, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 12, 2013ASSIGNED TO LIE
Monday, February 11, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 23, 2012NON-FINAL ACTION MAILED
Wednesday, November 21, 2012NON-FINAL ACTION WRITTEN
Friday, November 16, 2012ASSIGNED TO EXAMINER
Tuesday, July 31, 2012NOTICE OF PSEUDO MARK MAILED
Monday, July 30, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM